Author

Ellen S.Vitetta

Professor of Immunology and Microbiology, UT Southwestern - Cited by 35,860 - vaccines - immunotherapy

Biography

Distinguished Teaching Professor; Scheryle Simmons Patigian Distinguished Chair in Cancer Immunobiology. Research Interest: Antibody-based therapies, Cancer Dormancy, Nanotechnology, Vaccines.  Education: Medical School,New York University , Medicine Graduate School, New York Medical College (1966) Graduate School, New York Medical College (1968)
Title
Cited by
Year
TLR-independent neutrophil-derived IFN-γ is important for host resistance to intracellular pathogens
CR Sturge, A Benson, M Raetz, CL Wilhelm, J Mirpuri, ES Vitetta, ...Proceedings of the National Academy of Sciences 110 (26), 10711-10716, 2013201
139
2013
Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF
T Takeshima, LM Pop, A Laine, P Iyengar, ES Vitetta, R HannanProceedings of the National Academy of Sciences 113 (40), 11300-11305, 2016201
136
2016
A phase I study of a combination of anti‐CD19 and anti‐CD22 immunotoxins (Combotox) in adult patients with refractory B‐lineage acute lymphoblastic leukaemia
J Schindler, S Gajavelli, F Ravandi, YM Shen, S Parekh, I Braunchweig, ...British journal of haematology 154 (4), 471-476, 2011201
110
2011
The importance of cellular internalization of antibody-targeted carbon nanotubes in the photothermal ablation of breast cancer cells
R Marches, C Mikoryak, RH Wang, P Pantano, RK Draper, ES VitettaNanotechnology 22 (9), 095101, 2011201
81
2011
Pancreatic ductal adenocarcinoma: a review of immunologic aspects
MB Wachsmann, LM Pop, ES VitettaJournal of Investigative Medicine 60 (4), 643-663, 2012201
76
2012
Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection
CJ Roy, RN Brey, NJ Mantis, K Mapes, IV Pop, LM Pop, S Ruback, ...Proceedings of the National Academy of Sciences 112 (12), 3782-3787, 2015201
71
2015
Pilot phase IB clinical trial of an alhydrogel-adsorbed recombinant ricin vaccine
ES Vitetta, JE Smallshaw, J SchindlerClinical and Vaccine Immunology 19 (10), 1697-1699, 2012201
58
2012
Passive and active vaccination strategies to prevent ricin poisoning
SH Pincus, JE Smallshaw, K Song, J Berry, ES VitettaToxins 3 (9), 1163-1184, 2011201
48
2011
Ricin vaccine development
JE Smallshaw, ES VitettaRicin and Shiga Toxins: Pathogenesis, Immunity, Vaccines and Therapeutics …, 2012201
48
2012
Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis
SSM Soliman, C Baldin, Y Gu, S Singh, T Gebremariam, M Swidergall, ...Nature microbiology 6 (3), 313-326, 2021202
44
2021
Structure of RiVax: a recombinant ricin vaccine
PM Legler, RN Brey, JE Smallshaw, ES Vitetta, CB MillardActa Crystallographica Section D: Biological Crystallography 67 (9), 826-830, 2011201
39
2011
Immunotoxins constructed with chimeric, short-lived anti-CD22 monoclonal antibodies induce less vascular leak without loss of cytotoxicity
X Liu, LM Pop, J Schindler, ES VitettaMAbs 4 (1), 57-68, 2012201
27
2012
Rescue of rhesus macaques from the lethality of aerosolized ricin toxin
CJ Roy, DJ Ehrbar, N Bohorova, O Bohorov, D Kim, M Pauly, K Whaley, ...JCI insight 4 (1), 2019201
21
2019
Recent advances in the development of vaccines against ricin
RN Brey III, NJ Mantis, SH Pincus, ES Vitetta, LA Smith, CJ RoyHuman vaccines & immunotherapeutics 12 (5), 1196-11, 161
20
2016
Compositions and methods for homoconjugates of antibodies which induce growth arrest of apoptosis of tumor cells
MA Ghetie, JW Uhr, ES VitettaUS Patent 8,658,168, 141
20
2014
Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160
SH Pincus, K Song, GA Maresh, A Frank, D Worthylake, HK Chung, ...Journal of virology 91 (3), 10.1128/jvi. 01360-16, 2017201
19
2017
Identification of human anti-HIV gp160 monoclonal antibodies that make effective immunotoxins
SH Pincus, K Song, GA Maresh, DH Hamer, DS Dimitrov, W Chen, ...Journal of virology 91 (3), 10.1128/jvi. 055-16, 2017201
19
2017
A reevaluation of CD22 expression in human lung cancer
LM Pop, S Barman, C Shao, JC Poe, GM Venturi, JM Shelton, IV Pop, ...Cancer research 74 (1), 263-271, 2014201
18
2014
Passive immunization with an extended half-life monoclonal antibody protects Rhesus macaques against aerosolized ricin toxin
CJ Roy, G Van Slyke, D Ehrbar, ZA Bornholdt, MB Brennan, L Campbell, ...npj Vaccines 5 (1), 13, 2020202
14
2020
Partial depletion of regulatory T cells does not influence the inflammation caused by high dose hemi-body irradiation
S Ma, JA Richardson, A Bitmansour, TD Solberg, R Pidikiti, K Song, ...PloS one 8 (2), e56607, 202
13
2013

Referred From: https://scholar.google.com/citations?user=ge7Te9cAAAAJ&hl=en

Cited by
Citations 35860
h-index 103
i10-index 397
Recommended Journals
Open Access Journals